Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study

Ann‐Sofi Duberg, Charlotte Lybeck, Anna Fält, Scott Montgomery, Soo Aleman – 2 May 2022 – Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC), and surveillance is recommended for patients without cirrhosis when risk exceeds an incidence rate (IR) of 0.2%. Populations in Asia and sub‐Saharan Africa have been associated with HCC at younger ages, but the risk after immigration to Western countries should be investigated. The aim of this study was to study HCC by age and country of origin in people with chronic HBV infection in Sweden.

NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population

Claire E. Thomas, Brenda Diergaarde, Allison L. Kuipers, Jennifer J. Adibi, Hung N. Luu, Xuling Chang, Rajkumar Dorajoo, Chew‐Kiat Heng, Chiea‐Chuen Khor, Renwei Wang, Aizhen Jin, Woon‐Puay Koh, Jian‐Min Yuan – 2 May 2022 – It is difficult to identify people with nonalcoholic fatty liver disease (NAFLD) who are at high risk for developing hepatocellular carcinoma (HCC). A polygenic risk score (PRS) for hepatic fat (HFC‐PRS) derived from non‐Asians has been reported to be associated with HCC risk in European populations.

Patient Resources

It’s important to be able to communicate with patients effectively and AASLD has created resources to help you do that. See the growing list of tools at your disposal to print and deliver as you need.

Hepatology Training Pathways

By achieving American Board of Internal Medicine (ABIM) and/or American Board of Pediatric (ABP) certification in transplant hepatology, you demonstrate your commitment to the profession and show the public, your patients, your institution, and your colleagues that you have attained expertise in advanced and transplant hepatology beyond the general hepatology competence expected of a gastroenterologist.

Subscribe to